TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-TAK-385 Oral Solution

TAK-385 oral radiolabelled solution

DRUG

TAK-385 Tablets

TAK-385 tablets 2 X 40 mg

DRUG

[14C]-TAK-385 Solution for Intravenous Infusion

TAK-385 intravenous (IV) radiolabelled solution

Trial Locations (1)

Nottingham